Compare KMDA & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMDA | ITRG |
|---|---|---|
| Founded | 1990 | 1997 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.6M | 572.1M |
| IPO Year | 2013 | 2017 |
| Metric | KMDA | ITRG |
|---|---|---|
| Price | $7.67 | $2.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $14.00 | $5.13 |
| AVG Volume (30 Days) | 45.6K | ★ 2.2M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.94 | $67.34 |
| Revenue Next Year | $9.84 | $25.89 |
| P/E Ratio | ★ $24.59 | $45.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.50 | $1.43 |
| 52 Week High | $9.35 | $4.87 |
| Indicator | KMDA | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 35.75 | 30.89 |
| Support Level | $6.60 | N/A |
| Resistance Level | $7.85 | $3.29 |
| Average True Range (ATR) | 0.21 | 0.13 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 21.92 | 0.81 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.